Fact CheckerSign in

NCT02553525Enrolling by invitation

Effects of Stimulation Patterns of Deep Brain Stimulation

Source: ClinicalTrials.gov · Last updated 9 Apr 2026

Brief summary (registry, in English)

The purpose of this study is to measure the effects of non-regular temporal patterns of deep brain stimulation (DBS) on motor symptoms and neural activity in persons with Parkinson's disease (PD), essential tremor (ET), dystonia or multiple sclerosis (MS). These data will guide the design of novel stimulation patterns that may lead to more effective and reliable treatment with DBS. These data will also enable evaluation of current hypotheses on the mechanisms of action of DBS. Improving our understanding of the mechanisms of action of DBS may lead to full development of DBS as a treatment for Parkinson's disease and may lead to future applications of DBS.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
180 (estimated)
First submitted
15 Sept 2015
Start date
2 Jun 2016
Primary completion date
Mar 2027
Lead sponsor
Duke University
NCT number
NCT02553525

What you commit to

  • Study type: Interventional
  • Planned participants: 180
  • From 2 Jun 2016 to the primary completion date, Mar 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Inability to tolerate withholding anti-parkinsonian and/or anti-tremor medications

Other

  • Inability to execute the motor tasks during the study
  • Clinically ineffective DBS

Who the study is looking for

  • Diagnosis of Parkinson's Disease (PD), Essential Tremor (ET) dystonia or Multiple Sclerosis (MS)
  • Scheduled to undergo Deep Brain Stimulation (DBS) electrode implant, IPG implant or implanted pulse generator (IPG) replacement surgery
  • Neurologically stable
  • Able to understand the study and consent form

Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emory University
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Duke University
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status
University of Florida
Coordinator of this site? Confirm its status
GainesvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.